Drawing for JOURNAL OF PHARMACEUTICAL INNOVATION

USPTO serial 78888097

JOURNAL OF PHARMACEUTICAL INNOVATION

Reviewed by CopyMark Law Group

Reg. 3226229Status 710
Filing date
Status date
Registration date
Apr 3, 2007
Examiner
CLARK, ROBERT C
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with JOURNAL OF PHARMACEUTICAL INNOVATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David M. Abrahams

DAVID M ABRAHAMS WEBSTER, CHAMBERLAIN & BEAN1747 PENNSYLVANIA AVE NW STE 1000WASHINGTON, DC 20006-4693UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
016Printed publications, namely journals containing articles, research and review manuscripts concerning methods and techniques used by pharmaceutical professionals serving all aspects of the pharmaceutical industrySECTION 8 - CANCELLEDSep 23, 2006
041Providing online publications in the nature of journals containing articles, research and review manuscripts concerning methods and techniques used by pharmaceutical professionals serving all aspects of the pharmaceutical industrySECTION 8 - CANCELLEDSep 20, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 8, 2013C8..CANCELLED SEC. 8 (6-YR)
Apr 21, 2011CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 21, 2011COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 3, 2007R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Feb 20, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 15, 2007CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Feb 15, 2007IUAAUSE AMENDMENT ACCEPTED
Jan 25, 2007ACECAMENDMENT FROM APPLICANT ENTERED
Jan 25, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2007AUPCAMENDMENT TO USE PROCESSING COMPLETE
Jan 25, 2007ALIEASSIGNED TO LIE
Dec 26, 2006MAILPAPER RECEIVED
Dec 22, 2006IUAFUSE AMENDMENT FILED
Dec 22, 2006EAAUTEAS AMENDMENT OF USE RECEIVED
Oct 24, 2006GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2006DOCKASSIGNED TO EXAMINER
May 26, 2006NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance